Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.47+0.05 (+0.59%)
Close on Nov 17, 2026Market cap $3.17BP/E –Yield –
Bausch Health Companies total assets
Total assets on the balance sheet at the end of each period.
Bausch Health Companies's total assets was $25.48B at Sep 30, 2026. For fiscal 2025 it was $26.37B, down 0.6% from the year before. Over ten years it grew -6.0% a year on average. The highest annual figure on record is $48.97B in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.37B | -0.6% |
| FY2024 | Dec 31, 2024 | $26.52B | -3.0% |
| FY2023 | Dec 31, 2023 | $27.35B | +6.5% |
| FY2022 | Dec 31, 2022 | $25.69B | -12.0% |
| FY2021 | Dec 31, 2021 | $29.20B | -6.4% |
| FY2020 | Dec 31, 2020 | $31.20B | -7.9% |
| FY2019 | Dec 31, 2019 | $33.86B | +4.2% |
| FY2018 | Dec 31, 2018 | $32.49B | -13.3% |
| FY2017 | Dec 31, 2017 | $37.50B | -13.9% |
| FY2016 | Dec 31, 2016 | $43.53B | -11.1% |
| FY2015 | Dec 31, 2015 | $48.97B | +86.1% |
| FY2014 | Dec 31, 2014 | $26.30B | -5.8% |
| FY2013 | Dec 31, 2013 | $27.93B | +55.6% |
| FY2012 | Dec 31, 2012 | $17.95B | +36.9% |
| FY2011 | Dec 31, 2011 | $13.11B | +21.4% |
| FY2010 | Dec 31, 2010 | $10.80B | +424.2% |
| FY2009 | Dec 31, 2009 | $2.06B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $25.48B | -5.0% |
| Q2 FY2026 | Jun 30, 2026 | $24.79B | -9.1% |
| Q1 FY2026 | Mar 31, 2026 | $24.50B | -7.3% |
| Q4 FY2025 | Dec 31, 2025 | $26.37B | -0.6% |
| Q3 FY2025 | Sep 30, 2025 | $26.82B | +1.1% |
| Q2 FY2025 | Jun 30, 2025 | $27.27B | +2.9% |
| Q1 FY2025 | Mar 31, 2025 | $26.42B | -1.8% |
| Q4 FY2024 | Dec 31, 2024 | $26.52B | -3.0% |
| Q3 FY2024 | Sep 30, 2024 | $26.54B | -1.9% |
| Q2 FY2024 | Jun 30, 2024 | $26.50B | +3.9% |
| Q1 FY2024 | Mar 31, 2024 | $26.91B | +5.8% |
| Q4 FY2023 | Dec 31, 2023 | $27.35B | +6.5% |
| Q3 FY2023 | Sep 30, 2023 | $27.06B | +2.9% |
| Q2 FY2023 | Jun 30, 2023 | $25.50B | -9.5% |
| Q1 FY2023 | Mar 31, 2023 | $25.45B | -12.5% |
| Q4 FY2022 | Dec 31, 2022 | $25.69B | -12.0% |
| Q3 FY2022 | Sep 30, 2022 | $26.30B | -10.1% |
| Q2 FY2022 | Jun 30, 2022 | $28.17B | -6.2% |
| Q1 FY2022 | Mar 31, 2022 | $29.09B | -3.7% |
| Q4 FY2021 | Dec 31, 2021 | $29.20B | -6.4% |
| Q3 FY2021 | Sep 30, 2021 | $29.25B | -7.3% |
| Q2 FY2021 | Jun 30, 2021 | $30.04B | -4.3% |
| Q1 FY2021 | Mar 31, 2021 | $30.20B | -5.2% |
| Q4 FY2020 | Dec 31, 2020 | $31.20B | -7.9% |
| Q3 FY2020 | Sep 30, 2020 | $31.56B | -0.3% |
| Q2 FY2020 | Jun 30, 2020 | $31.40B | -3.0% |
| Q1 FY2020 | Mar 31, 2020 | $31.87B | -2.1% |
| Q4 FY2019 | Dec 31, 2019 | $33.86B | +4.2% |
| Q3 FY2019 | Sep 30, 2019 | $31.67B | -6.2% |
| Q2 FY2019 | Jun 30, 2019 | $32.35B | -6.1% |
| Q1 FY2019 | Mar 31, 2019 | $32.55B | -9.1% |
| Q4 FY2018 | Dec 31, 2018 | $32.49B | -13.3% |
| Q3 FY2018 | Sep 30, 2018 | $33.78B | -15.5% |
| Q2 FY2018 | Jun 30, 2018 | $34.45B | -17.5% |
| Q1 FY2018 | Mar 31, 2018 | $35.80B | -15.4% |
| Q4 FY2017 | Dec 31, 2017 | $37.50B | -13.9% |
| Q3 FY2017 | Sep 30, 2017 | $39.97B | – |
| Q2 FY2017 | Jun 30, 2017 | $41.73B | – |
| Q1 FY2017 | Mar 31, 2017 | $42.33B | – |
| Q4 FY2016 | Dec 31, 2016 | $43.53B | – |
See a number that looks wrong?